Psychotropic Drug Consumption at Admission and Discharge of Nursing Home Residents

Journal of the American Medical Directors Association

Volumn 13, Issue 4, 2012, Pages 407.e7-407.e12

  Rolland, Yves ^a,b,c   Andrieu, Sandrine ^a,b,c   Crochard, Anne ^d   Goni, Sylvia ^d   Hein, Christophe ^b   Vellas, Bruno ^a,b,c  

^a INSERM   (France)

^b UNIVERSITÉ PAUL SABATIER   (France)

^c TOULOUSE UNIVERSITY HOSPITAL   (France)

^d Lundbeck   (France)

Author keywords

Care transitions; Dementia; Nursing homes; Psychotropic drugs

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; HYPNOTIC AGENT; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NEUROLEPTIC AGENT;

ADULT; AGED; AGITATION; ANXIETY; APATHY; ARTICLE; CROSS-SECTIONAL STUDY; DELUSION; DEMENTIA; DESCRIPTIVE RESEARCH; DRUG EFFICACY; DRUG USE; FEMALE; HALLUCINATION; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITAL READMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MOOD CHANGE; NURSING HOME PATIENT; PRESCRIPTION; TREATMENT OUTCOME;

EID: 84860351969     PISSN: 15258610     EISSN: 15389375     Source Type: Journal    
DOI: 10.1016/j.jamda.2011.12.056     Document Type: Article

References (34)

1. Liperoti R., Mor V., Lapane K.L., et al. The use of atypical antipsychotics in nursing homes. J Clin Psychiatry 2003, 64:1106-1112.
2. Tolson D., Rolland Y., Andrieu S., et al. International Association of Gerontology and Geriatrics: A global agenda for clinical research and quality of care in nursing homes. J Am Med Dir Assoc 2011, 12:184-189.
3. Chen Y., Briesacher B.A., Field T.S., et al. Unexplained variation across US nursing homes in antipsychotic prescribing rates. Arch Intern Med 2011, 170:89-95.
4. Kamble P., Chen H., Sherer J.T., et al. Use of antipsychotics among elderly nursing home residents with dementia in the US: An analysis of National Survey Data. Drugs Aging 2009, 26:483-492.
5. Tjia J., Rothman M.R., Kiely D.K., et al. Daily medication use in nursing home residents with advanced dementia. J Am Geriatr Soc 2010, 58:880-888.
6. Rochon P.A., Stukel T.A., Bronskill S.E., et al. Variation in nursing home antipsychotic prescribing rates. Arch Intern Med 2007, 167:676-683.
7. Bronskill S.E., Rochon P.A., Gill S.S., et al. The relationship between variations in antipsychotic prescribing across nursing homes and short-term mortality: Quality of care implications. Med Care 2009, 47:1000-1008.
8. Snowdon J., Day S., Baker W. Why and how antipsychotic drugs are used in 40 Sydney nursing homes. Int J Geriatr Psychiatry 2005, 20:1146-1152.
9. Richter T., Mann E., Meyer G., et al. Prevalence of psychotropic medication use among German and Austrian nursing home residents: A comparison of 3 cohorts. J Am Med Dir Assoc 2012, 13:187.
10. Rolland Y., Abellan van Kan G., Hermabessiere S., et al. Descriptive study of nursing home residents from the REHPA network. J Nutr Health Aging 2009, 13:679-683.
11. Bloch F., Thibaud M., Dugue B., et al. Psychotropic drugs and falls in the elderly people: Updated literature review and meta-analysis. J Aging Health 2011, 23:329-346.
12. Jalbert J.J., Eaton C.B., Miller S.C., et al. Antipsychotic use and the risk of hip fracture among older adults afflicted with dementia. J Am Med Dir Assoc 2010, 11:120-127.
13. Cabrera M.A., Dellaroza M.S., Trelha C.S., et al. Psychoactive drugs as risk factors for functional decline among noninstitutionalized dependent elderly people. J Am Med Dir Assoc 2010, 11:519-522.
14. Schneider L.S., Dagerman K.S., Insel P. Risk of death with atypical antipsychotic drug treatment for dementia: Meta-analysis of randomized placebo-controlled trials. JAMA 2005, 294:1934-1943.
15. US Food and Drug Administration. FDA Public Health Advisory: Deaths with antipsychotics in elderly patients with behavioral disturbances. 2005. Available at: Accessed May 25, 2011. http://www.fda.gov/cder/drug/advisory/antipsychotics.htm.
16. Gill S.S., Bronskill S.E., Normand S.L., et al. Antipsychotic drug use and mortality in older adults with dementia. Ann Intern Med 2007, 146:775-786.
17. National Institute for Health and Clinical Excellence. Dementia. Supporting people with dementia and their carers in health and social care. Issue date 2006 (amended March 2011). Available at: Accessed January 9, 2012. http://www.nice.org.uk/nicemedia/live/10998/30318/30318.pdf.
18. Doody R.S., Stevens J.C., Beck C., et al. Practice parameter: Management of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2001, 56:1154-1166.
19. Haute Autorité de Santé. Programme AMI-Alzheimer: Alerte et Maitrise de la Iatrogénie des Neuroleptiques dans la Maladie d'Alzheimer 2007. Available at: Accessed May 25, 2011. http://www.has-sante.fr/portail/jcms/c_891528/programme-ami-alerte-maitrise-iatrogenie-alzheimer.
20. Folstein M.F., Folstein S.E., McHugh P.R. "Mini-mental state." A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975, 12:189-198.
21. Katz S., Downs T.D., Cash H.R., et al. Progress in development of the index of ADL. Gerontologist 1970, 10:20-30.
22. Cummings J.L., Mega M., Gray K., et al. The Neuropsychiatric Inventory: Comprehensive assessment of psychopathology in dementia. Neurology 1994, 44:2308-2314.
23. Mor V., Intrator O., Feng Z., et al. The revolving door of rehospitalization from skilled nursing facilities. Health Aff (Millwood) 2010, 29:57-64.
24. Murray L.M., Laditka S.B. Care transitions by older adults from nursing homes to hospitals: Implications for long-term care practice, geriatrics education, and research. J Am Med Dir Assoc 2010, 11:231-238.
25. McCloskey R.M. A qualitative study on the transfer of residents between a nursing home and an emergency department. J Am Geriatr Soc 2011, 59:717-724.
26. Ouslander J.G., Lamb G., Tappen R., et al. Interventions to reduce hospitalizations from nursing homes: Evaluation of the INTERACT II Collaborative Quality Improvement Project. J Am Geriatr Soc 2011, 59:745-753.
27. Gimbert V, Godot C, Centre d'analyse stratégique. July 2010. [Live together longer] (Vivre ensemble plus longtemps. Enjeux et opportunités pour l'action publique du vieillissement de la population française). Available at: Accessed January 9, 2012. http://www.strategie.gouv.fr/content/seminaire-quelle-organisation-de-l%E2%80%99offre-de-sante-dans-20-ans.
28. Haut Conseil pour l'avenir de l'assurance maladie. November 2010. Annual Report 2010 [Rapport annuel 2010. L'assurance maladie face à la crise :Eléments d'analyse]. Available at: Accessed January 9, 2012. http://www.securite-sociale.fr/IMG/pdf/hcaam_rapport2010.pdf.
29. Margallo-Lana M., Swann A., O'Brien J., et al. Prevalence and pharmacological management of behavioural and psychological symptoms amongst dementia sufferers living in care environments. Int J Geriatr Psychiatry 2001, 16:39-44.
30. Schneider L.S., Tariot P.N., Dagerman K.S., et al. Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease. N Engl J Med 2006, 355:1525-1538.
31. Sink K.M., Holden K.F., Yaffe K. Pharmacological treatment of neuropsychiatric symptoms of dementia: A review of the evidence. JAMA 2005, 293:596-608.
32. Ballard C., Corbett A. Management of neuropsychiatric symptoms in people with dementia. CNS Drugs 2010, 24:729-739.
33. Mann E., Kopke S., Haastert B., et al. Psychotropic medication use among nursing home residents in Austria: A cross-sectional study. BMC Geriatr 2009, 9:18.
34. Hanlon J.T., Handler S.M., Castle N.G. Antidepressant prescribing in US nursing homes between 1996 and 2006 and its relationship to staffing patterns and use of other psychotropic medications. J Am Med Dir Assoc 2010, 11:320-324.